Not known Facts About WST-8
Steer clear of coadministration of pazopanib with powerful CYP3A4 inhibitors if at all possible; if need to coadminister, decrease pazopanib dose to four hundred mg/dayMinor (1)dasatinib and pazopanib equally boost QTc interval. Minor/Importance Mysterious.If not able to avoid concomitant use, get ECGs and electrolytes just before and just after in